P63 and p73 are two homologues of the important tumor suppressor gene p53. In this study, we investigated p63 and p73 expression by immunocytochemistry using antibodies for TAp73 and p634A4 isoforms in 91 highgrade and 107 low-grade squamous intraepithelial lesions, 212 atypical squamous cells of undetermined significance, 9 squamous cell carcinomas and 63 normal samples from an Asian screening population together with 47 hospital samples of carcinomas. There was significant correlation between the TAp73 and p634A4 indices (Po0.0001). Significantly, higher TAp73 and p634A4 indices were found in high-grade lesions or carcinoma when compared with atypical squamous cells and low-grade lesions (Po0.0001). Among atypical squamous cells, p634A4 indices of cases that subsequently progressed to low-grade (P ¼ 0.031) or high-grade lesions (P ¼ 0.006) were significantly higher than those that did not. For atypical squamous cells positive for high-risk human papillomavirus (HPV) as detected by Digene (61%), cases with high p634A4 index were still more likely to have subsequent high-grade lesions detected (P ¼ 0.016). Among low-grade lesions, significantly higher TAp73 (P ¼ 0.038) was found in cases that subsequently progressed to high-grade lesions. There was significant correlation between presence of high-risk HPV and p634A4 index (P ¼ 0.01). In summary, p63 and p73 immunocytochemistry are potential good markers for detection of carcinoma and high-grade lesions in cervical cytology samples and for triage management of women with atypical squamous cells and low-grade Cervical cytology screening is effective in the prevention of cervical cancer by detecting asymptomatic cervical cancer and its precursors although there is limitation in its sensitivity and specificity. Among cytological abnormalities detectable in a screening population, atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL), especially the former, are the most common diagnostic categories.
Cervical cytology screening is effective in the prevention of cervical cancer by detecting asymptomatic cervical cancer and its precursors although there is limitation in its sensitivity and specificity. 1 Among cytological abnormalities detectable in a screening population, atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL), especially the former, are the most common diagnostic categories. [2] [3] [4] Both were associated with a higher possibility of subsequent development of cervical cancer when compared with women with negative cytology. 3 Colposcopic examination of all such cases poses significant demand on the community resources. To improve the efficiency of cervical cancer screening, human papillomaviruses (HPV) DNA testing has been introduced for the triage of women with ASC-US and for primary screening. 5, 6 Although HPV test shows high sensitivity, additional markers are necessary to improve the specificity of identifying cervical cancers or high-grade precursors. [7] [8] [9] [10] [11] It is also necessary to discover adjunct markers for management of LSIL as HPV testing is not so effective in triage management of LSIL.
p63 and p73 belong to the family of p53 proteins. p53 is the most extensively studied tumor suppressor gene in human cancers. p63 and p73, share both structural homology and functional similarities with p53. The latter includes activation of p53-downstream genes, regulation of cell cycle checkpoints and induction of apoptosis. [12] [13] [14] However, unlike p53, inactivating mutations of p63 and p73 in cancers are uncommon. [12] [13] [14] On the other hand, multiple isoforms of p63 [15] [16] [17] and p73 16, 18 exist. The full-length wild-type isoforms of p63 (TAp63) and p73 (TAp73) contain an NH2-terminal transactivation domain (TA) that can activate downstream target genes and induce apoptosis. In contrast, the NH2-terminal truncated forms, DNp63 and DNp73, lack the TA and exert negative regulatory effect on p53 and wild-type TAp73 and execute anti-apoptotic function. As a result, TAp63 and TAp73 are p53-synergistic, anti-oncogenic and pro-apoptotic nature, whereas DNp73 are oncogenic and anti-apoptotic 15, 16, [18] [19] [20] [21] Aberrant expression of p63 isoforms has been found in several human cancers [22] [23] [24] [25] [26] in association with specific cell type differentiation and progress of cancers. Dysregulated expression of p73 variants has been studied even more extensively. These studies, including our previous reports on cervical cancers, suggest that p73 isoforms are involved in human carcinogenesis correlating with prognosis, radiosensitivity and chemosensitivity. [27] [28] [29] [30] [31] In this study, we evaluated the expression of TAp73 and p634A4 isoforms in liquid-based cervical cytology samples of different diagnostic categories and correlated with follow-up profile of such cases.
Materials and methods

Clinical Samples
The residues of 529 ThinPrep-processed (Cytyc, Boxborough, MA, USA) cervical cytology samples were collected from the Department of Pathology, the University of Hong Kong, Queen Mary Hospital. The samples include 91 high-grade squamous intraepithelial lesions (HSIL), 107 LSILs, 212 ASC-US, 63 normal samples and 56 invasive cervical squamous cell carcinomas (Table 1 ). All except 47 carcinomas were archived samples from the Cervical Cytology Laboratory of the University of Hong Kong and they were collected from a screening population in Hong Kong. 2 The remaining cancer cases were collected from the laboratory and clinics of Queen Mary Hospital. The use of cytology residues was approved by the Institutional Ethics Review Board.
All the cases of ASC-US have been tested for highrisk HPV by the Digene Hybrid Capture Test II Test (Qiagen, USA). The cytology and histology followup data of the patients within 2-year after initial cytology diagnosis were retrieved. Such follow-up data were available in 193/212 (91%) of ASCUS and 106/107 (100%) of LSIL cases.
Cell Lines
The human cervical squamous cell carcinoma cell lines C4-1 and ME180 were obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in MEM (Life Technologies Inc., Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum and 1% penicillin and streptomycin. 30 
Preparation of Slides
The cell pellet of the liquid-based cytology residues of the above clinical samples collected after centrifuge was resuspended in PreservCyt solution. C4-1 and ME180 cells were detached from culture flasks, washed with PBS and fixed in PreservCyt solution. Thin-layer cytology slides were made using the ThinPrep 2000 Processor and were fixed in 95% alcohol 9 until use for immunocytochemistry.
Immunocytochemistry
Thin-layer cytology slides were dried overnight in an oven at 371C. Antigen retrieval was performed by heating immersed slides in 10 mM sodium citrate buffer, pH 6.0, at 951C in a microwave oven for 15 min. Endogenous peroxidases were blocked by treatment with 3% H 2 O 2 in methanol. Mouse antihuman p63, Clone 4A4 (Dako, Glostrup, Denmark) and mouse anti-human TAp73 (Zymed laboratories, CA, USA) were applied at the dilution of 1:1000 and 1:100, respectively. The anti-p63 4A4 antibody reacts with both TAp63 and DNp63 isoforms, whereas the antiTAp73 antibody detects the TAp73a isoform. Immunocytochemistry was performed using EnVision þ Dual Link System (Dako, Carpinteria, CA, USA). 32 A light hematoxylin counterstain was used. The cervical carcinoma cell lines ME 180 33 and C4-1 were used as positive control for p63 and p73, respectively. p63 and p73 immunoprofile in cervical cytology
Replacement of the primary antibody with preimmune IgG serum was used as a negative control. The experimental conditions were uniform for all samples.
Scoring for p63 and p73 Immunoreactivity
A modified Wentzensen scoring system 34 incorporating morphologic criteria was used for the assessment of the immunoreactivity of the cells for TAp73 and p634A4 ( Table 2 ). The whole slide was screened in each case. More than 10 epithelial groups in each slide with the highest immunoreactivity were assessed. Cells with atypical cytological features were evaluated for immunoreactivity and an immunocytochemical index of 0-4 was obtained. The immunoreactivity for TAp73 (Tsun and Cheung) and p634A4 (Ng and Cheung) in the samples were evaluated by two authors. If indicated, cases with discrepancy in scoring were discussed under multihead microscope. The specific cytological diagnosis of the samples was disclosed after the scoring was performed.
Statistical Analysis
Statistical analysis was performed using the Statistical Package for Social Science 16 for Windows (SPSS Inc., Chicago, IL, USA). The significance of difference in TAp73 and p634A4 expression among all cervical cytology diagnostic categories was examined by non-parametric Kruskal-Wallis H rank test and Chi-square test. The significance of difference between any two diagnostic groups was analyzed by non-parametric Mann-Whitney U test. Correlation coefficient was calculated by Pearson correlation test. All statistical tests were calculated in two-sided and P-value of o0.05 was considered statistically significant.
Results
The immunoreactivity for both p634A4 and TAp73 was predominantly found at the nuclei though weak cytoplasmic expression was focally and occasionally found (Figure 1 ). There was no apparent effect of storage on the immunoreactivity. A comparison of the p634A4 and TAp73 indices in different categories of cervical cytology diagnosis was summarized in Figure 2 and Table 3 . Although significant correlation between TAp73 and p634A4 indices (Po0.0001, Pearson test) was found, statistically significant difference in both indices among the different diagnostic categories (Po0.0001, Kruskal-Wallis test) was observed.
When compared with negative smears, ASC-US showed significant higher TAp73 index (Po0.0001, Mann-Whitney test) although no significant difference in p634A4 index was noted between the two categories. There was also no significant difference in TAp73 and p634A4 indices between ASC-US and LSIL. HSIL, however, showed significant higher TAp73 and p634A4 indices than LSIL (Po0.0001, Po0.0001, Mann-Whitney test). The two antibodies could also detect isolated small HSIL cells. There was no significant difference in TAp73 and p634A4 indices between HSIL and carcinomas.
We were able to retrieve the follow-up cytology and/or histology data in 193/212 (91%) of ASC-US and 106/107 (99.6%) of LSIL cases. Correlation between TAp73 and p634A4 indices in ASC-US samples and subsequent development of LSIL/HSIL were shown in Table 4 . Among cases of ASC-US, significantly higher p634A4 index was found in cases that subsequently progressed to LSIL (P ¼ 0.031) or HSIL (P ¼ 0.006) or above than those that did not. On the other hand, there was no statistically significant correlation with TAp73 index and subsequently development of LSIL (P ¼ 0.952) or HSIL (P ¼ 0.365).
Among the 212 ASC-US, 129 (61%) were positive for high-risk HPV as detected by Digene test. There was significant correlation between presence of high-risk HPV and p634A4 index (P ¼ 0.01) but not the TAp73 index (P ¼ 0.891). Among ASC-US cases positive for HPV, cases with high p634A4 index were more likely to have subsequent HSIL detected (P ¼ 0.016) whereas no predictive significance was found for subsequent detection of LSIL (P ¼ 0.124). There was no significant correlation in TAp73 index between HPV-positive ASC-US cases that have LSIL (P ¼ 1) or HSIL (P ¼ 0.42) or above subsequently detected.
Among LSIL, significantly higher TAp73 index (P ¼ 0.038) was also found in those cases that subsequently progressed to HSIL or above than those that did not (negative, ASC-US or LSIL) but no significant difference was observed for p634A4 (P ¼ 0.689).
Discussion
Novel Markers for Cervical Cytology
Cervical cancer screening by cytomorphological evaluation is one of the most successful cancer screening programs. Nevertheless, there still exist limitations in cervical cytology screening. New laboratory techniques are therefore being continuously explored to improve sensitivity and specificity of cervical cytology evaluation. The liquid-based cytologic preparation was popularly applied in the recent decade. It allows collection of exfoliated cervical epithelial cells in liquid buffer, reduces the interferring background of blood and inflammatory cells and improves the quality of the sample for screening of cancer cells. 2 Moreover, after the production of a thin layered cervical smear, the residual cells in the vial can conveniently be used for ancillary investigations.
HPV molecular test performed on directly collected samples or from liquid-based cell residues is currently the most commonly applied ancillary test to cervical cytology. 5, 6, 10 It enables triage of management of women with ASC-US, primary screening and followup of patients with cervical neoplasia. Besides HPV tests, cervical cytology samples can also be used for other evaluation including genetic and epigentic studies. 6, 10 The ploidy of epithelial cells and the immunohistochemical detection of expression of genetic markers can be assessed with an intact morphological background by immunocytochemistry and in situ hybridization enhancing identification of dysplastic cells. 8, 9, 35, 36 For instance, p16 immunohistochemical study on liquid-based cytology has been reported to be particularly hopeful in detection of cancer cells and their precursors although there still exist limitations in its application. 6, 36 Further exploration of novel biomarkers for identifying cervical cancers and their precursors is still an ongoing process.
We believe that combined cytopathologic evaluation and application of molecular markers in cervical cytology is a promising option to facilitate reliable detection of cervical cancer. Owing to the important roles of p63 and p73, the two homologues of p53, in cervical epithelial differentiation and carcinogenesis, the significance of immunoreactivity for p634A4 and TAp73 in liquid-based cervical cytology was evaluated in this study. The antip634A4 antibody recognizes both TAp63 and DNp63 isoforms, whereas the anti-TAp73 antibody detects the TAp73a isoform. They were selected for the study based on our previous experience on these two genes. 25, 26, 29, 37 
P63 and Cervical Epithelial Differentiation and Carcinogenesis
Upregulated expression of both TAp63 and DNp63 isoforms has been demonstrated in cervical intra- p63 and p73 immunoprofile in cervical cytology ANY Cheung et al epithelial neoplasia and invasive cancers. 4, 33 The expression of p63 gene was found to be associated with poor survival and local recurrence of cervical squamous cell carcinoma. 38 In this study, p634A4 immunoreactivity was found to be significantly higher in HSIL and cancers. The antibody can also detect isolated small HSIL cells and can improve the sensitivity of detecting these 'litigation' cells that are potentially easy to be missed.
P63 has been suggested to be useful to distinguish squamous and glandular lesions in cervical samples 39 and the endocervical glandular cells in this study was found to be negative for p634A4. In the squamous mucosa, p63 expression is often localized to the basal and parabasal cells of mature or metaplastic stratified squamous epithelium but may be present in all cell layers in atrophic epithelium. p63 is indeed considered as a marker for reserve cells or stem cell like cells. 25, [40] [41] [42] p63 expression by immunostaining alone may therefore highlight basal cells, which may become a diagnostic pitfall in atrophic samples. By combining p63 immunoreactivity assessment and morphological evaluation, such false positive results may be minimized.
P73 and Cervical Cancers
Dysregulated expression of p73 isoforms in cervical intraepithelial neoplasia and cervical cancer has been reported. 29, 43, 44 In our earlier studies, the expressions of DNp73 and TAp73 were found to be independently associated with prognosis of patients with cervical cancers. The two p73 isoforms have been found to be potential markers for predicting the prognosis and sensitivity to radiotherapy in patients with cervical squamous cell carcinoma. 29 In this study, TAp73 immunoreactivity was also found to be higher in HSIL and squamous cell carcinomas.
Correlation with Progress of Disease
CIN is actually a dynamic lesion capable of spontaneous regression or progression into more serious lesion including cancers. It is believed that biomarkers such as p16 can help in evaluating the likelihood for progression and regression in a particular CIN. 7 Such markers may be particularly useful in assisting triage of patients with borderline smears reported as ASC-US. Our study on an Asian screening population in Hong Kong showed that, similar to other screening populations, ASC-US is the most common abnormal cytologic finding 2 and is associated with a significantly higher chance to develop cervical cancer and its high-grade precursors.
3 HPV DNA test has been used for triage of ASCUS. However, majority of the ASC-US positive for highrisk HPV does not progress to high-grade cervical intraepithelial lesion. Management problem in women with LSIL also exists. Although more than 50% of LSIL will regress, HSIL or above can still be found in a significant portion of these women. 45 Women with LSIL may be referred for colposcopy or followed up with cytology with variation in management guidelines in different countries.
In this study, high p634A4 immunoreactivity correlated with higher likelihood of progressing to LSIL or HSIL lesions in subsequent cytology or histology follow-up among ASC-US cases independent of their HPV status. On the other hand, high TAp73 index in LSIL correlated with higher chance of progressing to HSIL or above. p634A4 may thus be a promising marker to further triage management of women with HPV-positive ASC-US whereas TAp73 is a good marker for deciding management of women with LSIL. Ancillary immunocytochemical studies for p634A4 and TAp73 can be performed in ASC-US and LSIL samples, respectively. Those with high p634A4 and TAp73 expression will be referred for colposcopy whereas those with low expression can be followed up with repeat cytology. This will reduce the burden of unnecessary colposcopy.
Reaction with HPV
HPV are recognized carcinogen for cervical cancers and their precursors. The E6 and E7 genes of highrisk HPV genotypes are essential in promoting degradation and/or inactivation of the p53 and retinoblastoma proteins, respectively, resulting in disruption of the important tumor suppressor functions of these two genes.
It is controversial whether there is a direct interaction between p63 and p73 with HPV viral oncoproteins. Interaction among HPV, p63 and p73 has been reported. A strong circumstantial association between p63 immunoreactivity and HPV 16 has been reported in earlier study because of their colocalization in squamous cell carcinomas. 46 Indeed, p63 is considered as a HPV target cell. 41 Recently, Teisser et al 47 reported that the p63 target genes could be activated by suppressing the E6/ E6AP pathway. In our study, significant correlation between presence of high-risk HPV and p634A4 index was found among cases of ASC-US.
Park et al 48 showed that p73 could also be inactivated by HPV-E6, but not by ubiquitin/proteasome-dependent mechanisms as in the case of p53. p73 promoter has also been shown to be affected, at least in cell lines and primary human keratinocytes, by E7 proteins from oncogenic HPV types. 43 Studies on p73À/À HPV38 E6/E7 transgenic mice keratinocytes also showed that loss of p53 could stop DNp73 expression and partially restore the UV-activated cell cycle checkpoints. On the other hand, loss of DNp73 led to restoration of the p53 pathways. 49 In this study, however, the DNp73 immunohistochemistry did not correlate with the HPV status.
p63 and p73 immunoprofile in cervical cytology In summary, in this immunocytochemical study on a relatively large number of liquid-based cytology samples, we showed that TAp73 and p634A4 immunoreactivity together with morphological assessment could distinguish cervical cancer and the high-grade precursors. In particular, p634A4 and TAp73 immunoreactivity correlated with subsequent detection of HSIL or above in patients with ASC-US and LSIL, respectively. Cases of ASC-US positive for p634A4 are also more likely to harbor high-risk HPV. p634A4 and TAp73 immunoreactivity may thus be useful potential markers for triage of borderline and low-grade cervical smears, respectively.
